MOZ-TIF2 interacts with CBP via the AD1 domain in vitro and in vivo. (A) Schematic representations of domains in TIF2, MOZ-TIF2, MOZ, and derivatives. bHLH-PAS, basic helix-loop-helix/Per-ARNT-Sim domain; NID, nuclear receptor interaction domain; Q, glutamine-rich domain; H1, histone H1/5-like domain, PHD, plant homeodomain; Zn, C2HC zinc finger. Residue-rich domains, acidic, proline and glutamine, and methionine. Residue numbers 1117 and 869 in MOZ-TIF2 indicate the amino acid breakpoints in MOZ and TIF2, respectively. Numbers 1290 and 1363 in MOZ-TIF2ΔAD1 indicate amino acid boundaries of the deleted AD1 domain. (B) In vitro-translated TIF2, MOZ, and MOZ-TIF2were tested for interaction with GST proteins or GST fused to the LBDs ERα or RXRα in the presence (+) or absence (−) of ligand. One-tenth of the total input of labeled protein is shown for comparison (10%). (C) Interactions of TIF2, MOZ, MOZ-N, MOZ-TIF2, and MOZ-TIF2ΔAD1 with GST, GST-CBP-SID (residues 2058 to 2130), and full-length GST-CBP as in (B). (D) Coimmunoprecipitation data showing in vivo interactions between ectopically expressed CBP and FLAG fusion proteins in HEK293 cells. (E) FRET analyses between CFP-CBP and YFP-MOZ-TIF2 or YFP-MOZ-TIF2ΔAD1. Representative nuclei showing fluorescence images pre- and post-YFP bleach are shown. (F) Percent FRET efficiencies (E%) for nuclei (15 and 10 nuclei, respectively). The line indicates the average E% value for each group. The differences in E% between the two groups were analyzed by using a two-tailed type 2 t test, and the P value is indicated.